Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PrEP news

Show

From To
Scotland must extend PrEP, not wait for HIV vaccine

Charities across Scotland and the UK called upon the government for access to pre-exposure prophylaxis (PrEP) as an effective means of preventing HIV infection. George Valiotis, CEO of HIV Scotland, told KaleidoScot: “We need to see leadership from Scottish Government on making access to PrEP a reality. The steps needed to make it happen must be clarified, and action taken to speed the process up.

Published
19 May 2015
From
KaleidoScot
PrEP Prescriptions on Dramatic Upswing in New York State

In less than a year, the number of New York State residents receiving Truvada (tenofovir/emtricitabine) as pre-exposure prophylaxis (PrEP) prescriptions through Medicaid has nearly tripled. According to Dan O’Connell, director of the AIDS Institute at the New York State Department of Health, from July 2013 through June 2014, 305 HIV-negative New Yorkers were taking Truvada to prevent infection with the virus. By the close of February 2015, that figure had jumped 272 percent to 832 people.

Published
14 May 2015
From
POZ
How PrEP Is Being Blocked By Bureaucracy

Bureaucracy and deliberate attempts to block prevention techniques are slowing down Los Angeles’s ability to disseminate PrEP.

Published
12 May 2015
From
The Advocate
Moving Video Shows HIV-Positive Men Asking for PrEP Approval in Australia

The Victorian AIDS Council (VAC) has released a video online featuring Australian community leaders who are living with HIV delivering a powerful message: They would still be HIV negative today if PrEP had been available to them prior to their seroconversion. The video is part of the campaign #approvePrEPdownunder, which is hoping to pressure the Australian government to approve PrEP for use in Australia.

Published
11 May 2015
From
TheBody.com
Five Sexy Gay Men On HIV PrEP Explain Why They Are Taking The Pill

So much of the conversation about pre-exposure prophylaxis (PrEP) has been reduced to labeling the people taking PrEP (“Truvada whore,” and more) instead of listening to them. Queerty wanted to get past those labels, so we spoke to five gay men on PrEP about why they chose to take a pill to prevent HIV infection — and their thoughts on the debate about it and the changes in their sexual lives that it inspired.

Published
11 May 2015
From
Queerty
ECDC comment on PrEP in Europe

On the basis of the new evidence, EU Members States should give consideration to integrating PrEP into their existing HIV prevention package for those most at-risk of HIV infection, starting with MSM. A key step towards roll-out of PrEP would be the review of the current regulatory approval of the medication (emtricitabine plus tenofovir disoproxil fumarate, Truvada®) to allow its use as prevention treatment in the EU/EEA, as strongly advocated by the European civil society organisations.

Published
05 May 2015
From
ECDC
Injectable PrEP: The Next Order of the Day

“The goal [for HIV prevention] is more choices,” said Raphael Landovitz, MD, MSc, Associate Professor of Medicine at the UCLA Center for Clinical AIDS Research and Education. “Injectable PrEP is the next order of the day.”

Published
05 May 2015
From
BETA blog
Gay and Bi Men Eager to Enter PrEP Demonstration Project

Transgender women and men who have sex with men have been eager to participate in the U.S. PrEP Demonstration Project, a real-world study of Truvada as pre-exposure prophylaxis.

Published
05 May 2015
From
AIDSMeds
David Cameron, Nick Clegg and Ed Miliband praise HIV prevention drug PrEP

The three main political party leaders in the UK have all praised the HIV prevention drug PrEP, during a Q&A for GT (Gay Times) Magazine.

Published
20 April 2015
From
Pink News
Pre-exposure prophylaxis works—it's time to deliver

The science is now clear: oral pre-exposure prophylaxis (PrEP) with a coformulation of tenofovir disoproxil fumarate and emtricitabine (Truvada) significantly reduces the risk of HIV infection among individuals at high risk of HIV infection. The news that PrEP has shown consistent efficacy among those who take it as prescribed should be a cause for celebration, and galvanise action to ensure access to PrEP for those who could benefit the most.

Published
17 April 2015
From
The Lancet
← First12345...42Next →

Filter by country